Matthew Hart to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Matthew Hart has written about TOR Serine-Threonine Kinases.
Connection Strength
0.865
-
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. Biochim Biophys Acta. 2016 05; 1862(5):992-1007.
Score: 0.494
-
mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging. Aging Cell. 2020 01; 19(1):e13057.
Score: 0.162
-
Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease. J Neurochem. 2013 Mar; 124(6):880-93.
Score: 0.101
-
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One. 2010 Apr 01; 5(4):e9979.
Score: 0.083
-
Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012 Oct 25; 223:102-13.
Score: 0.024